1. Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma.
   Selena Y Lin et al, 2021, Cells CrossRef
2. Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026
   Chen Mei et al, 2021, Front. Vet. Sci. CrossRef
3. Genome Editing in Organoid to Improve Understanding of Human Disease
   Binhui Zhou et al, 2022 CrossRef
4. Therapeutic Applications of the CRISPR-Cas System
   Kyungmin Kang et al, 2022, Bioengineering CrossRef
5. Delta-catenin attenuates medulloblastoma cell invasion by targeting EMT pathway
   Yuanjun Hu et al, 2022, Front. Genet. CrossRef
6. Exploring the role of tumor stemness and the potential of stemness-related risk model in the prognosis of intrahepatic cholangiocarcinoma
   Yuan Yue et al, 2023, Front. Genet. CrossRef
7. Applications of CRISPR-Cas System in Tumor Biology
   Mengdan Ma et al, 2021 CrossRef
8. Precision diagnostics in chronic lymphocytic leukemia: Past, present and future
   John Mollstedt et al, 2023, Front. Oncol. CrossRef
9. Applications and advancements of CRISPR-Cas in the treatment of lung cancer
   Yixin Ju et al, 2023, Front. Cell Dev. Biol. CrossRef